ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | -62.5% | 58,823 | -55.0% | 0.00% | 0.0% |
| Q2 2022 | $32,000 | -13.5% | 130,716 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $37,000 | -58.0% | 130,716 | -17.1% | 0.00% | -75.0% |
| Q4 2021 | $88,000 | -40.5% | 157,725 | +8.5% | 0.00% | -50.0% |
| Q3 2021 | $148,000 | -43.5% | 145,315 | -23.6% | 0.01% | -52.9% |
| Q2 2021 | $262,000 | -36.3% | 190,215 | -21.4% | 0.02% | -15.0% |
| Q1 2021 | $411,000 | +4.1% | 241,854 | +41.6% | 0.02% | -37.5% |
| Q4 2018 | $395,000 | – | 170,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |